Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

Psychopharmacology

Volumn 81, Issue 2, 1983, Pages 89-99

  Hjorth, S ^a   Carlsson, A ^a   Clark, D ^a   Svensson, K ^a   Wikstrom H ^a   Sanchez, D ^a   Lindberg, P ^a   Hacksell, U ^b   Arvidsson, L E ^b   Johansson, A ^b   Nilsson, J L G ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

3 PPP; Autoreceptor; Dopamine; Enantiomers; Novel antipsychotic; Postsynaptic receptor; Preferential limbic; Rat

Indexed keywords

AMPHETAMINE; APOMORPHINE; AUTORECEPTOR; DOPA; DOPAMINE; GAMMA BUTYROLACTONE; HALOPERIDOL; NEUROLEPTIC AGENT; NORADRENALIN; PRECLAMOL; RESERPINE; SEROTONIN;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; BEHAVIOR; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMPARISON; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG RESPONSE; ENANTIOMER; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MOTOR DYSFUNCTION; MUSCULOSKELETAL SYSTEM; NERVOUS SYSTEM; NONHUMAN; PHARMACOKINETICS; PSYCHOSIS; RAT; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; BIOGENIC AMINES; BRAIN CHEMISTRY; DEXTROAMPHETAMINE; MALE; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RESERPINE; STEREOISOMERISM;

EID: 0020602994     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF00428999     Document Type: Article

References (54)

1. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity
2. The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay
3. A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the tissue sample using a single column of strongly acidic cation exchange resin
4. Apomorphine-haloperidol interactions: Different types of antagonism in cortical and subcortical brain regions
5. Tardive dyskinesia
6. Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis
7. Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain
8. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine
9. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues
10. d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway
11. Effect of antipsychotic drugs and amphetamine on single cell activity
12. Dopaminergic autoreceptors
13. Antipsychotic drugs, neurotransmitters and schizophrenia
14. The search for new monoaminergic receptor agonists
15. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo
16. Is 3-PPP a potential antipsychotic agent?
17. Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioural studies
18. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice
19. The nucleus accumbens — possible site of antipsychotic action of neuroleptic drugs
20. The anatomical basis for feedback and feedforward in the striatonigral system
21. Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography
22. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats
23. Effects of 3-PPP on persistent neuroleptic-induced dyskinesias in Cebus monkeys
24. 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity
25. The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists
26. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors
27. Pharmacological manipulation of central dopamine (DA) autoreceptors — biochemical and behavioural consequences
28. Dopamine in the basal ganglia. Its role and therapeutic implications
29. Structure-activity relationships of the butyrophenones and diphenylbutylpiperidines
30. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain
31. Evidence for a receptor-mediated feed-back control of striatal tyrosine hydroxylase activity
32. Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy
33. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum
34. The role of the corpus striatum in neuroleptic-and narcotic-induced catalepsy
35. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism
36. Simultaneous determination of femtomole quantities of 5-hydroxytryptophan, serotonin and 5-hydroxyindole-acetic acid in brain using HPLC with electrochemical detection
37. Simultaneous determination of dopamine, dopac and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system
38. Evidence for activation of dopaminergic autoreceptors by (-)-3-PPP
39. TL-99 and 3-PPP, differential action in producing contraversive turning in the 6-OHDA-lesioned rat
40. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99
41. Effect of 3-PPP, a putative dopamine autoreceptor agonist, on rat serum prolactin levels
42. Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain
43. Dopamine autoreceptors: Pharmacology, function and comparison with post-synaptic dopamine receptors
44. Locus of action of antipsychotic drugs
45. Simultaneous measurement of 5-hydroxytryptophan and l-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions
46. Extrapyramidal syndromes and other neurological side effects of psychotropic drugs
47. A fluorimetric method for the estimation of tyrosine in plasma and tissues
48. Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation
49. Dopaminergic neurons in the rat ventral tegmental area. III: Effects of d- and l-amphetamine
50. Inhibition of postsynaptic dopamine-sensitive adenylate cyclase in carp retina by the putative dopamine autoreceptor agonist 3-PPP
51. Effects of dopamine autoreceptor agonists at α2-adrenoceptors